Discovery of common and rare genetic risk variants for colorectal cancer Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Registries
  • Rheumatic Diseases

abstract

  • © 2018, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10−8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.

authors

publication date

  • January 2019

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1038/s41588-018-0286-6

PubMed ID

  • 30510241

Additional Document Info

start page

  • 76

end page

  • 87

volume

  • 51

number

  • 1